LSI chosen to give plenary talk at American Transplant Congress 2018

IMG_20180605_083353

Work in our lab on using synthetic biomarkers to noninvasively detect the onset of acute transplant rejection, spearheaded by graduate student Quoc Mac, was chosen as a plenary talk at the 2018 American Transplant Congress in Seattle, WA. We are excited to share our technology with scientists and clinicians around the country and world!

ATC 2018 is a joint meeting of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST), bringing together nearly 5,000 attendees and exhibitors—a diverse mix of physicians, surgeons, scientists, nurses, organ procurement personnel, advanced transplant providers, pharmacists, administrators, and other transplant professionals. The five-day event features nearly 1,800 abstracts, 500+ oral presentations, and more than 1,200 poster presentations, all delivered in a way that encourages the exchange of new clinical and scientific information and supports an interchange of opinions regarding care management and socioeconomic, ethical, and regulatory issues relevant to organ and tissue transplantation.